leadf
logo-loader
viewGenedrive PLC

Genedrive PLC - Result of AGM

RNS Number : 1706K
Genedrive PLC
30 December 2020
 

 

genedrive plc

("genedrive" or the "Company")

 

Result of AGM

 

Genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that at the Annual General Meeting, held today, all resolutions proposed were duly passed.

 

For information, details of the proxy voting are shown below:

 


Votes For

Vote For (as % of votes cast)

Votes Against

Votes Against (as % of votes cast)

Votes withheld

1 Receive the Annual report and accounts for the Company

18,105,091

99.6%

76,514

0.4%

98,780

2 Approve the Directors Remuneration Report

18,004,341

99.2%

143,950

0.8%

131,981

3 Re-appoint Tom Lindsay as a director

18,046,634

99.4%

105,545

0.6%

128,206

4 Re-appoint Chris Yates as a director

18,049,104

99.4%

103,075

0.6%

128,206

5 Re-appoint David Budd as a director

18,020,957

99.2%

148,510

0.8%

110,918

6 Re-appoint Matthew Fowler as a director

18,049,104

99.4%

103,075

0.6%

128,206

7 Re-appoint Ian Gilham as a director

16,874,853

99.3%

120,159

0.7%

1,285,373

8 Re-appointment of RSM UK as auditors of the Company

18,062,908

99.6%

79,628

0.4%

137,849

9 Directors authority to allot shares

17,902,887

98.7%

229,670

1.3%

147,828

10 Disapplication of pre-emption rights

16,773,042

92.6%

1,341,787

7.4%

165,041

 

 

The full text of each of the resolutions is set out in the notice of Annual General Meeting, copies of which are available on the Company's website (www.genedriveplc.com).

 

 

 

For further details please contact:

 

genedrive plc

+44 (0)161 989 0245

David Budd: CEO / Matthew Fowler: CFO




Peel Hunt LLP (Nominated Adviser and Joint Broker)

+44 (0)20 7418 8900

James Steel / Oliver Jackson




finnCap (Joint Broker)

+44 (0)20 7220 0500

Geoff Nash / Kate Bannatyne / Alice Lane




Walbrook PR Ltd (Media & Investor Relations)

+44 (0)20 7933 8780 or genedrive@walbrookpr.com

Paul McManus / Anna Dunphy

+44 (0)7980 541 893 / +44 (0)7876 741 001

 

 

About genedrive plc (http://www.genedriveplc.com)

genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Company has assays on market for the detection of HCV, certain military biological targets, and has tests in development for tuberculosis (mTB). The Company recently released a high throughput SARS-CoV-2 assay and has in development a Genedrive® Point of Care version of the assay, both based on Genedrive® chemistry.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGBDBDDLSXDGGG

Quick facts: Genedrive PLC

Price: -

Market: AIM
Market Cap: -
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Market Report: FTSE falls and UK inflation up to 0.7% on back of rising food...

FTSE 100 opened in the red after the latest inflation data came in higher than forecasts. London’s leading index lost 14 points to 6,734 in early trading.   UK prices rose 0.7% in the year to January and are expected to jump further as demand increases over the next months. Food and more...

1 week, 1 day ago

4 min read